Global obesity therapeutics sector hits US$3.92 billion in 2024, targeting US$20.84 billion by 2033 at 20.6% CAGR. Uncover trends in MC4-R agonists, next-gen mechanisms, and investments like Rhythms Pharmaceuticals' 40% growth driving cost-effective solutions. https://finance.yahoo.com/news/competitive-landscape-obesity-therapeutics-market-141800112.html